[EN] AZAINDAZOLES AS BTK KINASE MODULATORS AND USE THEREOF<br/>[FR] AZAINDAZOLES COMME MODULATEURS DE LA KINASE BTK ET LEUR UTILISATION
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2011019780A1
公开(公告)日:2011-02-17
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, (I) are useful as kinase modulators, including Btk modulation, wherein A1, A2, A3, R4, are as defined herein.
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, (I) are useful as kinase modulators, including Btk modulation, wherein A
1
, A
2
, A
3
, R
4
are as defined herein.
Improvements in and relating to (3-aryl-5-isothiazolyl)ureas
申请人:ELI LILLY AND COMPANY
公开号:EP0129407A2
公开(公告)日:1984-12-27
Novel (3-aryl-5-isothiazolyl)-ureas, which are useful as aquatic algicides, terrestrial herbicides, and aquatic herbicides, are described herein. These ureas are prepared from the corresponding 5-amino-3-arylisothiazoles with a ureido forming reagent. Further provided are methods of use and formulations comprising these urea products.
Azaindazoles as Btk kinase modulators and use thereof
申请人:Bristol-Myers Squibb Company
公开号:EP2789615A1
公开(公告)日:2014-10-15
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof,
are useful as kinase modulators, including Btk modulation, wherein A1, A2, A3, R4, are as defined herein.